Investigation announced for Investors in Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) over potential Wrongdoing by certain directors

An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Reviva Pharmaceuticals Holdings, Inc.

Investors who purchased shares of Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Reviva Pharmaceuticals Holdings officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

Cupertino, CA based Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases.

On April 15, 2024, Reviva Pharmaceuticals Holdings, Inc. filed with the SEC a current report on Form 8-K. In this current report, Reviva Pharmaceuticals announced that "the Company's previously issued financial statements for the fiscal year ended December 31, 2022 included in its Annual Report on Form 10-K, the interim financial statements for the quarterly period ended September 30, 2022 included in its Quarterly Report on Form 10-Q, and each of the interim financial statements for the quarterly periods in fiscal 2023 included in its Quarterly Reports on Form 10-Q (cumulatively, the "Restatement Periods") should be restated to correct historical errors related principally to the timing of recognition of the Company's estimated accrual of certain research and development expenses, and should therefore no longer be relied upon."

Shares of Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) declined from over $8 per share in May 2023 to as low as $1.60 per share on May 15, 2024.

Those who purchased shares of Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.